As part of a quarterly update, the biggest publicly traded exchange-traded fund (ETF) for the cannabis space added 10 new cannabis stocks.
The Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) completed its quarterly rebalance and updated investors on its new holdings on Tuesday (March 19).
With these new additions, Horizons ETFs Management confirmed the ETF now has 59 cannabis stocks in its holding list.
Horizons ETFs indicated that, as of March 15, the ETF had netted a return of 58.95 percent over a year-to-date period.
Here is a list of the stocks added to HMMJ’s portfolio:
- 48North Cannabis (TSXV:NRTH)
- AgraFlora Organics International (CSE:AGRA,OTC Pink:PUFXF)
- Cannara Biotech (CSE:LOVE)
- Charlotte’s Web Holdings (CSE:CWEB,OTCQX:CWBHF)
- The Flowr Corporation (TSXV:FLWR,OTC Pink:FLWPF)
- Heritage Cannabis Holdings (CSE:CANN,OTC Pink:HERTF)
- ICC International Cannabis (CSE:WRLD.U,OTC Pink:WLDCF)
- PharmaCielo (TSXV:PCLO)
- Westleaf (TSXV:WL,OTCQB:WSLFF)
- Zenabis Global (TSXV:ZENA)
ETF management team sees potential in rising US CBD market
Horizons ETFs highlighted a new sector of the overall market it will be exploring moving forward: hemp-derived cannabidiol (CBD).
“According to a study by the Brightfield Group, the US legal CBD industry alone could be worth US$22 billion within the next two years, which puts that single market by itself at roughly the same target market size of the entire Canadian Marijuana industry,” Steve Hawkins, president and CEO of Horizons ETFs, said in a press release.
The ETF managers pointed to the addition of Charlotte’s Web as its intent to capitalize on this booming CBD space.
This Colorado-based company holds a market capitalization of just over C$368 million. Shares of the firm have increased in value over a year-to-date period by 44.82 percent to reach a price of C$21.71.
As part of its previous rebalancing in December 2018, Horizons ETFs included Khiron Life Sciences (TSXV:KHRN,OTCQB:KHRNF), MediPharm Labs (TSXV:LABS,OTCQB:MLCPF) and Auxly Cannabis Group (TSXV:XLY,OTCQX:CBWTF) to the mix.
In September 2018, HMMJ crossed the C$1-billion mark for assets managed in its holdings.
The space for ETFs focused on the cannabis market has grown with the addition of other funds attracting investors. HMMJ remains as a passively managed index designed to offer investors a basket of North American companies with significant interests in the marijuana space.
Other cannabis-centric ETFs have differentiated by offering active management, appointing a portfolio manager and making sure to actively add or drop stock in a company depending on the evolution of the market.
Following the success of HMMJ, Horizons ETFs launched an additional publicly traded ETF to focus on smaller ventures in the marijuana market.
The Horizons Emerging Marijuana Growers Index ETF (NEO:HMJR) made its debut in February 2018.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Cannara Biotech, The Flowr Corporation, Heritage Cannabis Holdings, Khiron Life Sciences and MediPharm Labs are clients of the Investing News Network. This article is not paid-for content.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/